Robert W. Baird’s latest rating for TMDX stock


TransMedics Group Inc.’s filing revealed that its VP, Global Regulatory Affairs Provost Miriam unloaded Company’s shares for reported $0.18 million on Aug 31. In the deal valued at $66.52 per share,2,708 shares were sold. As a result of this transaction, Provost Miriam now holds 23,611 shares worth roughly $ 1.51 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, Weill David bought 2,500 shares, generating $155,000 in total proceeds. Upon buying the shares at $62.00, the Director now owns 13,693 shares.

Before that, Hassanein Waleed H sold 7,500 shares. TransMedics Group Inc. shares valued at $697,929 were divested by the President & CEO at a price of $93.06 per share. As a result of the transaction, Hassanein Waleed H now holds 536,691 shares, worth roughly $34.4 million.

Robert W. Baird initiated its TransMedics Group Inc. [TMDX] rating to an Outperform in a research note published on Tuesday.

Price Performance Review of TMDX

On Tuesday, TransMedics Group Inc. [NASDAQ:TMDX] saw its stock fall -7.26% to $64.10. On the same session, the stock had its day’s lowest price of $63.83, but rose to a high of $69.91. Over the last five days, the stock has gained 4.94%. TransMedics Group Inc. shares have risen nearly 3.86% since the year began. Nevertheless, the stocks have risen 23.48% over the past one year. While a 52-week high of $99.63 was reached on 07/19/23, a 52-week low of $38.86 was recorded on 01/09/23. SMA at 50 days reached $78.11, while 200 days put it at $71.82. A total of 0.77 million shares were traded, compared to the trading of 0.54 million shares in the previous session.

Levels Of Support And Resistance For TMDX Stock

The 24-hour chart illustrates a support level at 61.98, which if violated will result in even more drops to 59.87. On the upside, there is a resistance level at 68.06. A further resistance level may holdings at 72.03. The Relative Strength Index (RSI) on the 14-day chart is 39.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.80, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 59.90%. Stochastics %K at 78.14% indicates the stock is a holding.

How much short interest is there in TransMedics Group Inc.?

A steep rise in short interest was recorded in TransMedics Group Inc. stocks on Aug 14, 2023, dropping by -0.2 million shares to a total of 3.67 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 3.87 million shares. There was a decline of -5.45%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 13.03% of the overall stock float, the days-to-cover ratio (short ratio) fell to 4.43.

TransMedics Group Inc. [TMDX] – Who Are The Largest Shareholders?

In filings from Fidelity Management & Research Co, it is revealed that the company now owns 2,975,180 shares, or roughly 9.14% of the outstanding TMDX shares. In other words, the investor’s shares have fallen by -268,538 from its previous 13-F filing of 3243718.0. Additionally, BlackRock Fund Advisors increased 2.50% of its stake after which the total value it holdings stand at $192,656,639, while Lord, Abbett & Co. LLC added 0.84% of its stake to hold $174.22 million in the firm. Over the last quarter, The Vanguard Group, Inc. purchased 59,156 shares of TransMedics Group Inc., while Macquarie Investment Management B bought -51,191 shares. At present, Fred Alger Management LLC is holding 1,649,508 shares valued at $153.7 million. Allspring Global Investments LLC owned 1,279,051 shares of the company at the time of its most recent 13F filing, worth $119.18 million.

According to FactSet, TransMedics Group Inc.’s share price will average $96.20 in the next year, based on opinions of analysts polled by the firm. This is up nearly 43.23 percent from its previous closing price of $69.12. Analysts expect TransMedics Group Inc. stock to reach the higher price of $110.00, while the lowest price estimate is $81.00. However, 6 analysts have rated TMDX stock as a Buy in their predictions for 2023.


Please enter your comment!
Please enter your name here